See more : Saturn Oil & Gas Inc. (SOIL.V) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Pharmaceuticals Holding Co., Ltd, a leading company in the Medical – Distribution industry within the Healthcare sector.
- Marubeni Corporation (8002.T) Income Statement Analysis – Financial Results
- Japan Tobacco Inc. (2914.T) Income Statement Analysis – Financial Results
- Fortitude Group, Inc. (FRTD) Income Statement Analysis – Financial Results
- Kinnevik AB (KINV-B.ST) Income Statement Analysis – Financial Results
- HolidayCheck Group AG (HOC.DE) Income Statement Analysis – Financial Results
Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK)
About Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 260.30B | 231.98B | 215.82B | 191.91B | 186.57B | 159.08B | 130.85B | 120.76B | 105.52B | 92.40B | 78.22B | 68.08B | 54.90B | 37.41B | 19.57B | 16.55B | 13.92B | 11.41B | 10.70B | 10.81B | 9.79B | 7.24B | 5.20B | 4.60B | 4.53B | 4.41B | 339.81M | 320.97M | 337.35M | 241.25M | 225.70M |
| Cost of Revenue | 229.37B | 201.49B | 187.28B | 164.47B | 159.75B | 136.52B | 114.12B | 106.53B | 92.72B | 80.99B | 67.98B | 58.79B | 46.88B | 30.62B | 17.85B | 15.10B | 12.70B | 10.62B | 10.00B | 9.79B | 8.77B | 6.22B | 4.49B | 4.00B | 3.97B | 3.89B | 291.77M | 270.37M | 291.90M | 205.82M | 193.76M |
| Gross Profit | 30.93B | 30.49B | 28.54B | 27.44B | 26.81B | 22.56B | 16.72B | 14.23B | 12.80B | 11.40B | 10.24B | 9.29B | 8.02B | 6.79B | 1.72B | 1.45B | 1.22B | 792.02M | 702.03M | 1.02B | 1.01B | 1.02B | 710.35M | 591.47M | 559.93M | 526.69M | 48.04M | 50.60M | 45.45M | 35.43M | 31.94M |
| Gross Profit Ratio | 11.88% | 13.14% | 13.23% | 14.30% | 14.37% | 14.18% | 12.78% | 11.79% | 12.13% | 12.34% | 13.09% | 13.64% | 14.60% | 18.15% | 8.77% | 8.74% | 8.78% | 6.94% | 6.56% | 9.44% | 10.33% | 14.10% | 13.66% | 12.87% | 12.36% | 11.93% | 14.14% | 15.76% | 13.47% | 14.68% | 14.15% |
| Research & Development | 2.20B | 2.11B | 1.99B | 1.66B | 1.35B | 1.06B | 790.35M | 670.55M | 617.69M | 512.32M | 454.71M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.71B | 1.20B | 1.41B | 1.32B | 1.38B | 1.18B | 1.51B | 1.28B | 1.20B | 1.13B | 1.08B | 1.10B | 912.56M | 885.75M | 430.05M | 352.29M | 309.98M | 259.78M | 252.71M | 396.59M | 353.26M | 491.95M | 331.48M | 237.39M | 216.66M | 199.09M | 15.10M | 15.93M | 12.01M | 6.43M | 5.78M |
| Selling & Marketing | 9.19B | 14.28B | 13.32B | 12.86B | 12.86B | 11.06B | 7.41B | 6.07B | 5.35B | 4.83B | 4.41B | 3.97B | 3.29B | 3.01B | 657.42M | 719.81M | 625.50M | 357.67M | 363.47M | 506.19M | 480.45M | 338.90M | 199.87M | 166.62M | 156.35M | 175.32M | 3.72M | 3.90M | 2.88M | 1.95M | 785.74K |
| SG&A | 19.77B | 15.48B | 14.73B | 14.19B | 14.24B | 12.24B | 8.92B | 7.35B | 6.55B | 5.96B | 5.49B | 5.07B | 4.20B | 3.89B | 1.09B | 1.07B | 935.48M | 617.45M | 616.18M | 902.78M | 833.71M | 830.85M | 531.35M | 404.01M | 373.01M | 374.41M | 18.82M | 19.82M | 14.89M | 8.38M | 6.56M |
| Other Expenses | 1.29B | 4.12B | 3.90B | 3.46B | 3.30B | 144.35M | -23.35M | 484.55M | 522.88M | 547.93M | 185.18M | 271.57M | 187.73M | 183.65M | -12.30M | 39.76M | 25.24M | 43.87M | 61.03M | 69.57M | 55.11M | 36.63M | 7.56M | 9.30M | 9.63M | 22.02M | 22.72M | -268.33K | 350.12K | 1.36M | 651.23K |
| Operating Expenses | 23.26B | 21.71B | 20.62B | 19.30B | 18.88B | 16.33B | 11.75B | 9.97B | 8.85B | 8.01B | 7.34B | 6.62B | 5.58B | 4.91B | 1.11B | 1.10B | 956.41M | 629.97M | 631.97M | 925.19M | 850.26M | 843.15M | 544.31M | 413.14M | 379.31M | 380.50M | 20.44M | 20.82M | 15.62M | 9.08M | 6.65M |
| Cost & Expenses | 252.63B | 223.20B | 207.90B | 183.77B | 178.64B | 152.85B | 125.87B | 116.50B | 101.56B | 89.00B | 75.32B | 65.41B | 52.47B | 35.53B | 18.96B | 16.20B | 13.65B | 11.25B | 10.63B | 10.72B | 9.63B | 7.06B | 5.04B | 4.42B | 4.35B | 4.27B | 312.22M | 291.19M | 307.52M | 214.90M | 200.41M |
| Interest Income | 387.82M | 438.30M | 338.18M | 288.33M | 234.02M | 197.40M | 161.39M | 172.00M | 137.99M | 207.04M | 242.11M | 304.45M | 262.92M | 47.25M | 10.59M | 8.38M | 20.81M | 18.51M | 19.72M | 23.41M | 15.53M | 7.79M | 8.15M | 17.55M | -0.20 | -0.31 | -0.56 | -0.64 | -0.45 | -0.87 | -0.02 |
| Interest Expense | 1.66B | 1.69B | 1.52B | 1.41B | 1.41B | 1.20B | 875.74M | 645.06M | 613.27M | 584.93M | 413.75M | 472.38M | 461.80M | 213.48M | 113.25M | 156.53M | 141.70M | 127.34M | 47.80M | 36.43M | 52.13M | 30.55M | 13.36M | 55.04M | 48.32M | 63.73M | 20.89M | 11.96M | 8.94M | 3.94M | 2.95M |
| Depreciation & Amortization | 2.19B | 2.22B | 2.14B | 2.14B | 1.88B | 1.17B | 839.98M | 746.09M | 672.56M | 585.01M | 549.71M | 536.59M | 479.17M | 382.74M | 93.21M | 94.21M | 96.44M | 69.14M | 59.11M | 74.23M | 70.28M | 72.32M | 50.37M | 50.13M | 43.37M | 21.42M | -3.05M | 11.67M | 8.48M | 3.33M | 1.63M |
| EBITDA | 10.90B | 12.44B | 10.55B | 10.44B | 9.35B | 6.72B | 6.24B | 5.46B | 4.97B | 4.56B | 3.92B | 3.79B | 3.65B | 2.89B | 2.63B | 437.45M | 384.69M | 150.09M | 205.63M | 298.01M | 362.42M | 316.35M | 263.51M | 303.24M | 223.99M | 154.48M | 27.60M | 29.78M | 29.84M | 26.35M | 25.29M |
| EBITDA Ratio | 4.19% | 5.18% | 5.54% | 6.04% | 5.80% | 5.52% | 5.26% | 5.41% | 5.54% | 5.70% | 5.59% | 6.08% | 7.33% | 7.72% | 3.70% | 3.55% | 3.05% | 2.61% | 1.92% | 2.79% | 3.89% | 4.37% | 5.11% | 7.02% | 5.12% | 3.80% | 8.12% | 9.28% | 8.84% | 10.92% | 11.20% |
| Operating Income | 7.67B | 9.01B | 8.21B | 7.18B | 8.93B | 5.21B | 5.23B | 4.21B | 3.69B | 3.27B | 3.07B | 2.80B | 2.87B | 2.08B | 370.75M | 163.64M | 122.60M | 84.58M | 61.22M | 150.11M | 219.52M | 191.62M | 203.34M | 218.45M | 137.51M | 89.95M | 30.64M | 18.11M | 21.36M | 23.02M | 23.66M |
| Operating Income Ratio | 2.95% | 3.89% | 3.80% | 3.74% | 4.79% | 3.27% | 4.00% | 3.48% | 3.49% | 3.54% | 3.93% | 4.11% | 5.23% | 5.55% | 1.89% | 0.99% | 0.88% | 0.74% | 0.57% | 1.39% | 2.24% | 2.65% | 3.91% | 4.75% | 3.04% | 2.04% | 9.02% | 5.64% | 6.33% | 9.54% | 10.48% |
| Total Other Income/Expenses | -612.94M | -206.30M | -61.67M | -8.91M | -2.67B | 135.05M | -23.35M | 252.89M | 485.24M | 530.19M | 186.54M | 291.85M | 161.37M | 101.57M | 57.96M | 23.07M | 23.95M | -61.82M | 37.51M | 40.69M | 38.36M | 21.86M | -1.00M | -6.20M | 430.25K | 1.09M | -34.27M | -249.02K | 208.16K | 1.18M | -235.73K |
| Income Before Tax | 7.05B | 8.81B | 8.14B | 7.18B | 6.26B | 5.34B | 5.20B | 4.64B | 4.17B | 3.80B | 3.26B | 3.09B | 3.04B | 2.17B | 354.96M | 186.71M | 146.55M | 101.47M | 98.72M | 190.80M | 257.88M | 213.48M | 202.34M | 222.28M | 137.94M | 109.58M | 29.68M | 17.86M | 21.57M | 24.20M | 23.43M |
| Income Before Tax Ratio | 2.71% | 3.80% | 3.77% | 3.74% | 3.36% | 3.36% | 3.98% | 3.84% | 3.95% | 4.11% | 4.17% | 4.54% | 5.53% | 5.81% | 1.81% | 1.13% | 1.05% | 0.89% | 0.92% | 1.76% | 2.64% | 2.95% | 3.89% | 4.84% | 3.05% | 2.48% | 8.73% | 5.56% | 6.39% | 10.03% | 10.38% |
| Income Tax Expense | 1.89B | 1.82B | 1.87B | 1.57B | 1.43B | 887.12M | 1.15B | 809.28M | 807.49M | 807.72M | 634.23M | 627.14M | 589.07M | 393.55M | 91.47M | 57.27M | 51.07M | 40.28M | 25.89M | 52.29M | 50.39M | 50.25M | 27.57M | 17.62M | 27.10M | 19.75M | 989.11K | 2.65M | 3.22M | 3.60M | 3.56M |
| Net Income | 3.77B | 5.62B | 5.09B | 4.50B | 4.08B | 3.88B | 3.52B | 3.20B | 2.88B | 2.59B | 2.24B | 2.05B | 2.04B | 1.37B | 173.33M | 81.98M | 66.28M | 68.71M | 50.52M | 93.14M | 154.45M | 125.85M | 145.28M | 184.84M | 94.43M | 78.73M | 28.69M | 15.21M | 18.35M | 20.60M | 19.87M |
| Net Income Ratio | 1.45% | 2.42% | 2.36% | 2.34% | 2.19% | 2.44% | 2.69% | 2.65% | 2.73% | 2.80% | 2.87% | 3.02% | 3.72% | 3.66% | 0.89% | 0.50% | 0.48% | 0.60% | 0.47% | 0.86% | 1.58% | 1.74% | 2.79% | 4.02% | 2.08% | 1.78% | 8.44% | 4.74% | 5.44% | 8.54% | 8.80% |
| EPS | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | 1.37 | 1.31 | 1.19 | 1.07 | 0.96 | 0.82 | 0.76 | 0.84 | 0.73 | 0.65 | 0.14 | 0.12 | -0.08 | 0.09 | 0.16 | 0.24 | 0.22 | 0.25 | 0.34 | 0.20 | 0.12 | 0.13 | 0.06 | 0.07 | 0.08 | 0.04 |
| EPS Diluted | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | 1.37 | 1.31 | 1.19 | 1.07 | 0.96 | 0.82 | 0.76 | 0.84 | 0.73 | 0.65 | 0.14 | 0.12 | -0.08 | 0.09 | 0.16 | 0.24 | 0.22 | 0.25 | 0.34 | 0.20 | 0.12 | 0.13 | 0.06 | 0.07 | 0.08 | 0.04 |
| Weighted Avg Shares Out | 3.70B | 3.48B | 2.84B | 2.84B | 2.83B | 2.83B | 2.69B | 2.69B | 2.69B | 2.69B | 2.69B | 2.69B | 2.42B | 1.99B | 1.99B | 569.33M | 571.36M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M |
| Weighted Avg Shares Out (Dil) | 3.70B | 3.49B | 2.85B | 2.85B | 2.83B | 2.83B | 2.69B | 2.69B | 2.69B | 2.69B | 2.69B | 2.69B | 2.42B | 1.99B | 1.99B | 569.33M | 571.36M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M | 487.47M |
Source: https://incomestatements.info
Category: Stock Reports